NCT07700511

Brief Summary

Background: The National Institute of Neurological Disorders and Stroke (NINDS) often enrolls healthy volunteers in certain studies. These studies allow researchers to look for causes of diseases and disorders by comparing affected people to healthy ones. Prescreening lets volunteers participate in multiple studies without having to repeat the screening tests each time. Having a registry of prescreened volunteers also makes it easier for researchers to reach people willing to participate in their studies. Objective: To create a registry of healthy volunteers who have been prescreened for NINDS research studies. Eligibility: Healthy people aged 18 years and older. Design: Participants will have 1 clinic visit for prescreening. This visit will take about 5 hours. The visit may be spread across 1 to 3 days. Participants will have the following procedures: A physical exam, including height, weight, and vital signs. A review of their medical history and medications. They will also provide personal data such as age, sex, and years of education. An exam of their nervous system. This will include tests of their strength and reflexes, following an object with their eyes, and other tasks. Cognitive tests. These tests will check their memory, attention, and thinking. A magnetic resonance imaging (MRI) scan. They will lie on a table that slides into a cylinder; Magnetic fields will create images of their brain. Handedness. They will complete a questionnaire about what hand they use for most tasks. Participants may remain on the healthy volunteers list for 2 years. If they wish to participate longer, they will need to return to repeat all of the screening tests.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
96mo left

Started Feb 2027

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
7 months until next milestone

Study Start

First participant enrolled

February 8, 2027

Expected
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2035

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2035

Last Updated

July 14, 2026

Status Verified

July 8, 2026

Enrollment Period

7.9 years

First QC Date

July 11, 2026

Last Update Submit

July 11, 2026

Conditions

Keywords

Healthy VolunteerHealthy ParticipantPre-screening

Outcome Measures

Primary Outcomes (1)

  • To screen and create a temporary list of volunteers in good health for participation in NINDS studies (Volunteer List) in order to reduce costs, inconvenience to volunteers, and duplication of effort.

    From enrollment/consent until withdrawal from the registry or study closure.

Study Arms (1)

Healthy volunteers

Healthy volunteers

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy Volunteers

You may qualify if:

  • To be eligible to participate in this study, an individual must meet all the following criteria:
  • Stated interest in, and availability for, participating in NINDS studies and willingness to comply with the procedures of this protocol.
  • At least 18 years of age.
  • Ability to understand and willingness to sign a written informed consent document.
  • Fluent in English, or another language that allows the use of a validated MoCA or MoCA Duo to be completed (see the following list of languages Paper (mocacognition.com) or Digital tools (mocacognition.com))

You may not qualify if:

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Major neurological or neurobehavioral disorder, such as seizure disorder, multiple sclerosis, major depression, or schizophrenia.
  • Substance use disorder or illicit substance use.
  • Deafness or blindness to a degree which would make participation in studies impossible, e.g., inability to communicate with investigators or read instructions.
  • Identified major health concerns (e.g., uncontrolled diabetes mellitus, congestive heart failure, liver cirrhosis, malignancy requiring ongoing cytotoxic chemotherapy, immunotherapy, or radiation) as evidenced by screening medical history.
  • Presence of implanted electronic devices, e.g., pacemakers, or other implanted object(s) making MRI unsafe or whose safety cannot be ascertained.
  • Inability to tolerate MRI scanning for any reason.
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Links

Study Officials

  • Eric M Wassermann, M.D.

    National Institute of Neurological Disorders and Stroke (NINDS)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Eric M Wassermann, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2026

First Posted

July 14, 2026

Study Start (Estimated)

February 8, 2027

Primary Completion (Estimated)

January 8, 2035

Study Completion (Estimated)

January 8, 2035

Last Updated

July 14, 2026

Record last verified: 2026-07-08

Locations